Literature DB >> 10200914

Neuropsychological functioning among cardiac rehabilitation patients.

D J Moser1, R A Cohen, M M Clark, M S Aloia, B A Tate, S Stefanik, D E Forman, P L Tilkemeier.   

Abstract

PURPOSE: The underlying pathophysiology contributing to coronary heart disease also predisposes patients to cerebrovascular disease and associated cognitive disorders. Although prior studies have focused on the neuropsychological sequelae of specific cardiac problems, few have examined the associated cognitive capacities and limitations of typical cardiac patients. The current study was designed to examine neuropsychological functioning among a sample of cardiac rehabilitation (CR) patients.
METHODS: Using neuropsychological instruments, patients were compared in a CR program to age-matched outpatient control subjects who had no known history of cardiac or neurologic disease. Cardiac rehabilitation patients were then divided into dichotomous subgroups based on whether they had undergone coronary artery bypass grafting, had experienced a myocardial infarction, had hypertension, or had impaired ejection fraction. Neuropsychological functioning was examined relative to each of these factors.
RESULTS: Cardiac rehabilitation patients had poorer neuropsychological test performance than did control subjects, with subtle relative deficits on measures of response generation, memory, and verbal abstraction, and particularly verbal fluency. Low ejection fraction, hypertension, and prior coronary artery bypass graft were associated with greater relative neuropsychological impairments.
CONCLUSIONS: Although CR patients were not grossly neuropsychologically impaired as a group, it appears highly likely that many within a given program exhibit some degree of neuropsychological dysfunction. Including neuropsychological screening as part of pre-CR testing would help to identify such patients. This information may help staff to impart health care information in a manner that is most effective for the individual patient and may also be useful in the formation of realistic goals.

Entities:  

Mesh:

Year:  1999        PMID: 10200914     DOI: 10.1097/00008483-199903000-00002

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil        ISSN: 0883-9212            Impact factor:   2.081


  18 in total

Review 1.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

2.  Blood pressure variability and white matter hyperintensities in older adults with cardiovascular disease.

Authors:  John Gunstad; Ronald A Cohen; David F Tate; Robert H Paul; Athena Poppas; Karin Hoth; Kristin L Macgregor; Angela L Jefferson
Journal:  Blood Press       Date:  2005       Impact factor: 2.835

3.  C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease.

Authors:  John Gunstad; Linda Bausserman; Robert H Paul; David F Tate; Karin Hoth; Athena Poppas; Angela L Jefferson; Ronald A Cohen
Journal:  J Clin Neurosci       Date:  2006-05-24       Impact factor: 1.961

4.  Vascular and cognitive functions associated with cardiovascular disease in the elderly.

Authors:  Ronald A Cohen; Athena Poppas; Daniel E Forman; Karin F Hoth; Andreana P Haley; John Gunstad; Angela L Jefferson; David F Tate; Robert H Paul; Lawrence H Sweet; Mokato Ono; Beth A Jerskey; Marie Gerhard-Herman
Journal:  J Clin Exp Neuropsychol       Date:  2008-06-16       Impact factor: 2.475

5.  Relation of brain natriuretic peptide levels to cognitive dysfunction in adults > 55 years of age with cardiovascular disease.

Authors:  John Gunstad; Athena Poppas; Steven Smeal; Robert H Paul; David F Tate; Angela L Jefferson; Daniel E Forman; Ronald A Cohen
Journal:  Am J Cardiol       Date:  2006-06-28       Impact factor: 2.778

6.  Neuroimaging and cardiac correlates of cognitive function among patients with cardiac disease.

Authors:  Robert H Paul; John Gunstad; Athena Poppas; David F Tate; Dan Foreman; Adam M Brickman; Angela L Jefferson; Karin Hoth; Ronald A Cohen
Journal:  Cerebrovasc Dis       Date:  2005-07-05       Impact factor: 2.762

7.  Cognitive processing speed mediates the effects of cardiovascular disease on executive functioning.

Authors:  Spencer W Liebel; Erin C Jones; Assaf Oshri; Emily S Hallowell; Beth A Jerskey; John Gunstad; Lawrence H Sweet
Journal:  Neuropsychology       Date:  2016-11-14       Impact factor: 3.295

8.  Vascular Health and Cognitive Function in Older Adults with Cardiovascular Disease.

Authors:  Daniel E Forman; Ronald A Cohen; Karin F Hoth; Andreana P Haley; Athena Poppas; David J Moser; John Gunstad; Robert H Paul; Angela L Jefferson; David F Tate; Makoto Ono; Nicole Wake; Marie Gerhard-Herman
Journal:  Artery Res       Date:  2008-02-01       Impact factor: 0.597

9.  A fMRI Study of Verbal Working Memory, Cardiac Output, and Ejection Fraction in Elderly Patients with Cardiovascular Disease.

Authors:  Farzin Irani; Lawrence H Sweet; Andreana P Haley; John J Gunstad; Beth A Jerskey; Richard C Mulligan; Angela L Jefferson; Athena Poppas; Ronald A Cohen
Journal:  Brain Imaging Behav       Date:  2009-12       Impact factor: 3.978

10.  Evaluation of retinal and choroidal changes in patients with Alzheimer's type dementia using optical coherence tomography angiography.

Authors:  Ze-Bing Li; Zhong-Jing Lin; Na Li; Huan Yu; Yan-Lin Wu; Xi Shen
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.